Ezetimibe

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

76 Suppliers, 30 USDMF, 10 JDMF, 15 EU WC, 61 KDMF, 17 NDC API, 50 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

27 Suppliers

27 Suppliers

DOSSIERs // Finished Dosage Forms

463 Dossiers, 62 FDA Orange Book, 227 Europe, 21 Canada, 21 Australia, 35 South Africa, 97 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 19 BASF, 18 Roquette, 14 Gangwal Healthcare, 13 Microlex e.U, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 8 Gangwal Chemicals, 7 Seppic, 7 DFE Pharma, 6 SPI Pharma, 6 Pluviaendo, 6 Lonza Capsugel, 5 Pharmatrans-Sanaq, 5 Prachin Chemical, 5 Boai NKY Pharmaceuticals Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 DKSH, 4 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 3 Novo Excipients, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Alcedo Pharmachem, 2 Minakem, 2 Nanjing Well Pharmaceutical, 2 Ulanqab Kema New Material, 2 Jai Radhe Sales, 1 ACG Worldwide, 1 Qualicaps, 1 Pharm-RX Chemical, 1 NEWEDGE Overseas, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Chynops Pharma, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 41 Direct Compression, 27 Granulation, 25 Controlled & Modified Release, 23 Lubricants & Glidants, 18 Thickeners and Stabilizers, 16 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Solubilizers, 9 Film Formers & Plasticizers, 9 Taste Masking, 7 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Parenteral, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Topical, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 200 Finished Drug Prices

MARKET PLACE

18 APIs, 5 DOSSIERS // FDF

PATENTS

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 BioAnalytical Methods, 2 USP, 2 Others

DIGITAL CONTENT

8 Data Compilation & Company Tracker #PharmaFlow, 108 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Ezetimibe. Original Data : Therapeutic Goods Administration Website

Ezetimibe

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

76 Suppliers

30 USDMF

10 JDMF

15 EU WC

61 KDMF

17 NDC API

50 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

27 Suppliers

DOSSIERs // Finished Dosage Forms

463 Dossiers

62 FDA Orange Book

227 Europe

21 Canada

21 Australia

35 South Africa

97 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

19 BASF

18 Roquette

14 Gangwal Healthcare

13 Microlex e.U

12 Sigachi Industries

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Corel Pharma Chem

8 Gangwal Chemicals

7 Seppic

7 DFE Pharma

6 SPI Pharma

6 Pluviaendo

6 Lonza Capsugel

5 Pharmatrans-Sanaq

5 Prachin Chemical

5 Boai NKY Pharmaceuticals Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 DKSH

4 Ingredion Pharma Solutions

4 Vasa Pharmachem

3 Novo Excipients

3 Kima Chemical

2 The Dow Chemical Company

2 Alcedo Pharmachem

2 Minakem

2 Nanjing Well Pharmaceutical

2 Ulanqab Kema New Material

2 Jai Radhe Sales

1 ACG Worldwide

1 Qualicaps

1 Pharm-RX Chemical

1 NEWEDGE Overseas

1 Qianhao Chemical (Hebei) Co., Ltd

1 Chynops Pharma

1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons